Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

BioXcel Therapeutics (BTAI) Other Gross PP&E Adjustments (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Other Gross PP&E Adjustments data on record, last reported at $712000.0 in Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments rose 117.78% year-over-year to $712000.0; the TTM value through Sep 2025 reached $712000.0, up 117.78%, while the annual FY2024 figure was -$9000.0, 99.79% up from the prior year.
  • Other Gross PP&E Adjustments reached $712000.0 in Q3 2025 per BTAI's latest filing, up from $250000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $712000.0 in Q3 2025 and bottomed at -$7.3 million in Q3 2023.
  • Average Other Gross PP&E Adjustments over 4 years is -$2.5 million, with a median of -$2.7 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 803.09% in 2023, then skyrocketed 117.78% in 2025.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$1.7 million in 2022, then plummeted by 144.87% to -$4.3 million in 2023, then soared by 99.79% to -$9000.0 in 2024, then skyrocketed by 8011.11% to $712000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $712000.0 in Q3 2025, $250000.0 in Q2 2025, and $336000.0 in Q1 2025.